Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Hodgkin Lymphoma through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 58 active trials
6 drugs · 92 active trials
Outside the funnel: Phase not stated 2. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 10 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Dacarbazine | Phase 4 | Phase 4 | 23 | 10 | 10 | 48 | 0 | — | — | Jan 25, 1994 |
| Doxorubicin | Phase 4 | Phase 4 | 22 | 9 | 15 | 56 | 0 | — | — | Jan 25, 1994 |
| Bendamustine | Phase 4 | Phase 4 | 6 | 1 | 2 | 29 | 0 | — | — | 2008-06 |
| Tislelizumab | Phase 4 | Phase 4 | 5 | 3 | 3 | 10 | 0 | — | — | Apr 21, 2017 |
| Sintilimab | Phase 4 | Phase 4 | 2 | 1 | 0 | 2 | 0 | — | — | Jul 1, 2021 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.